Using artificial neural networks to accelerate flowsheet optimization for downstream process development
Biotechnology and Bioengineering · 2024-08 · 121 (8) · 2318-2331
DOI: 10.1002/bit.28454 ↗At a glance
Journal article in Biotechnology and Bioengineering, published online on 2023-05-31. Written by Daphne Keulen and 5 co-authors. Institution: Department of Biotechnology, Delft University of Technology, Delft, The Netherlands. Major MEDLINE topics: Neural Networks, Computer, Drug Contamination, Chromatography. Cited 17 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: GlaxoSmithKline Biologicals S.A. (Belgium).
Abstract (original language)
An optimal purification process for biopharmaceutical products is important to meet strict safety regulations, and for economic benefits. To find the global optimum, it is desirable to screen the overall design space. Advanced model‐based approaches enable to screen a broad range of the design‐space, in contrast to traditional statistical or heuristic‐based approaches. Though, chromatographic mechanistic modeling (MM), one of the advanced model‐based approaches, can be speed‐limiting for flowsheet optimization, which evaluates every purification possibility (e.g., type and order of purification techniques, and their operating conditions). Therefore, we propose to use artificial neural networks (ANNs) during global optimization to select the most optimal flowsheets. So, the number of flowsheets for final local optimization is reduced and consequently the overall optimization time. Employing ANNs during global optimization proved to reduce the number of flowsheets from 15 to only 3. From these three, one flowsheet was optimized locally and similar final results were found when using the global outcome of either the ANN or MM as starting condition. Moreover, the overall flowsheet optimization time was reduced by 50% when using ANNs during global optimization. This approach accelerates the early purification process design; moreover, it is generic, flexible, and regardless of sample material's type.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biotechnology, Delft University of Technology, Delft, The Netherlands.
- GSK, Technical Research & Development-Microbial Drug Substance, Rixensart, Belgium.
Funding
- GlaxoSmithKline Biologicals S.A. (Belgium)
Cite
APA
Keulen, D., Hagen, E. V., Geldhof, G., Le Bussy, O., Pabst, M., & Ottens, M. (2024). Using artificial neural networks to accelerate flowsheet optimization for downstream process development. Biotechnology and Bioengineering, 121(8), 2318-2331. https://doi.org/10.1002/bit.28454
Vancouver
Keulen D, Hagen EV, Geldhof G, Le Bussy O, Pabst M, Ottens M. Using artificial neural networks to accelerate flowsheet optimization for downstream process development. Biotechnology and Bioengineering. 2024;121(8):2318-2331. doi:10.1002/bit.28454
BibTeX
@article{Keulen2024,
author = {Keulen, Daphne and Hagen, Erik van der and Geldhof, Geoffroy and Le Bussy, Olivier and Pabst, Martin and Ottens, Marcel},
title = {Using artificial neural networks to accelerate flowsheet optimization for downstream process development},
journal = {Biotechnology and Bioengineering},
year = {2024},
volume = {121},
number = {8},
pages = {2318--2331},
doi = {10.1002/bit.28454}
}
EUVIMED